– Sources
Needham Maintains Buy on Vacasa, Lowers Price Target to $10
Needham analyst Bernie McTernan maintains Vacasa (NASDAQ:VCSA) with a Buy and lowers the price target from $13 to $10.
Related Posts
Lockheed Martin Q3 EPS $2.21 Beats $1.97 Estimate, Sales $16.00B Miss $17.12B Estimate
Lockheed Martin (NYSE:LMT) reported quarterly earnings of $2.21 per share which beat the analyst consensus estimate of $1.97 by 12.18 percent. This is a 64.64 percent decrease over earnings of $6.25 per share from the
Peabody Sees FY22 Capex $210M
Fourth Quarter 2022 Outlook
Seaborne Thermal
Export volume is expected to be 2.4 million tons, less than previously thought primarily due to lower production from our 50 percent ownership of the
Wellness Company Milestone: First CBD Brand To Attain Three NSF Certifications For Sports
cbdMD, Inc. (AMEX: YCBD), one of the nation's leading and widely recognized CBD companies, announced the release of the third product in its comprehensive NSF-Certified for Sport line of CBD products.